Cancer Drug Comparisons Released By NCCN, Include Affordability

The National Comprehensive Cancer Network unveils its first two sets of cancer drug comparisons, for multiple myeloma and chronic myelogenous leukemia, using graphical displays to help physicians and patients make treatment choices.